Do Weight Loss Injections Reduce Employee Sick Days? (October 2026)

01 · The short answer

Do weight loss injections reduce sick days?

The claim is plausible in theory but unproven. Mounjaro (tirzepatide) is licensed in the UK for weight management in adults and for type 2 diabetes.¹ Its licence says nothing about fewer sick days. Articles that quote a specific percentage drop in absence are normally quoting an economic model, which estimates savings from assumptions about health, productivity and cost.

That does not mean the idea is foolish. Conditions linked to excess weight can cause time off work, and a treatment that helps someone lose weight alongside a reduced-calorie diet and more activity may, over time, help with some of them. It is a reasonable hope, not a result.

02 · Is this relevant to me?

What this means if you are an employee or employer

If you are considering treatment, decide on health grounds, not on the promise of fewer sick days. Ask whether you meet the licensed criteria, whether you can follow a reduced-calorie diet and stay active, and whether you can manage the early weeks of side effects. Our weight loss clinic guide explains how treatment works from the start.

If you are an employer or HR lead, treat absenteeism savings as a possible secondary benefit rather than a business case. Any scheme should rest on individual clinical suitability, confidentiality and informed choice. Nobody should feel pressured to take a prescription medicine for the sake of attendance figures, and a prescriber must decide who is suitable, not a workplace policy.

03 · What to do next

The sensible next step

If you meet the licensed criteria and want to explore treatment, start with a free online consultation reviewed by a GPhC-registered prescriber. If you want to see how registration works, read our guide to registering for weight loss injections online.

If you would like more answers before deciding, our weight loss injections FAQs cover common questions in plain language.

04 · Evidence versus models

What the absenteeism evidence really is

The idea that weight loss injections cut sick days usually reaches the public through economic modelling, not through a trial that tracked attendance. A model starts with assumptions about how much weight people lose, how that changes the risk of other conditions, and how those conditions affect time off work. It then multiplies those assumptions across a workforce. The result looks precise, but it is only as sound as the inputs.

This matters because the models are sometimes written by or for organisations with an interest in the answer. Insurers, consultancies and drug makers each have reasons to present a particular picture, and readers should treat any single projection with caution.

It also helps to separate three ideas that often get blurred. The first is absenteeism, meaning days away from work. The second is presenteeism, meaning being at work but less productive. The third is long-term healthcare cost. A treatment might affect any of these differently, and a model that bundles them together can make one benefit look larger than the evidence for it allows.

What is supported is narrower. Mounjaro is a once-weekly injectable prescription medicine made by Eli Lilly, licensed in the UK for weight management in adults and for type 2 diabetes.¹ It is used alongside a reduced-calorie diet and increased physical activity, and individual results vary.¹ None of this includes a promise about attendance.

For a person deciding what to do, this means the honest framing is simple. Weight management may bring health benefits that could, over time and for some people, reduce reasons for absence. Whether that happens for you depends on your health, your job and how you respond to treatment. Nobody can responsibly tell you a number in advance.

For employers, the lesson is the same. A projected saving is an argument for taking employee health seriously, not a forecast to put in a budget. If a vendor or article gives you a precise percentage reduction in sick leave, ask what trial or dataset it comes from, who paid for it, and whether it measured attendance directly. If those answers are vague, treat the figure as marketing.

Finally, remember that workplace health initiatives in general can influence absence through many routes, including support, flexibility and management culture. A medicine is one possible tool among many, and it works best when it sits within wider support rather than replacing it.

05 · How tirzepatide works

How Mounjaro works and what it is licensed for

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.¹ It comes as a pre-filled multi-dose pen, the KwikPen, in every strength from 2.5mg to 15mg.¹

The mechanism is what sets it apart from some older options. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹

This dual action distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide, which is sold as Wegovy and Ozempic.¹

Why does the mechanism matter for work? Because the way the medicine acts on appetite and digestion explains both its intended effect and many of its early side effects. Slower stomach emptying is part of why people feel fuller, and it is also part of why nausea or constipation can appear. Knowing this helps you plan, for example by avoiding a big presentation or long journey on the day after a dose increase while you see how you feel.

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ For an employee, that means stopping treatment does not make side effects disappear overnight, and any effect that was bothering you may take time to settle.

It is worth being clear about what the licence covers and what it does not. A licence describes the conditions the medicine has been tested and approved for, along with the safety information that goes with them. It does not describe workplace productivity, and no regulator has approved a claim about sick leave. The medicine is for weight management and type 2 diabetes, and any workplace benefit is secondary and uncertain.

Mounjaro is prescription-only. It is supplied only after an online consultation reviewed by a GPhC-registered prescriber, and this page is information, not a substitute for medical advice.¹³ If you are unsure whether it suits you, the prescriber reviewing your consultation will decide, and you are free to stop at any point before ordering.

06 · Side effects and working days

Side effects that can affect your working days

Side effects can cost some people working time, especially early on, so they belong in any honest conversation about absence. Like all medicines, Mounjaro can cause side effects, and most are digestive.¹ The most common — affecting more than 1 in 10 people — are nausea, diarrhoea, vomiting, constipation and abdominal discomfort.¹³ Common effects (up to 1 in 10) include indigestion, reduced appetite, dizziness, reflux, burping, hair shedding and injection-site reactions.¹³ Serious side effects are uncommon. Get medical help straight away for severe, persistent stomach pain, signs of a severe allergic reaction, or yellowing of the skin or eyes.

Timing is the useful part for planning. Side effects are most likely when starting treatment or moving up a dose, and for most people they ease within days to a few weeks as the body adjusts.¹ Most follow a pattern: they appear in the first days after starting or increasing a dose, peak early, and settle as your body adapts.¹ This is one reason Mounjaro uses a gradual dose ladder.

Fatigue is a recognised common side effect, most noticeable in the first weeks and after dose increases. It usually reflects a mix of the body adjusting and simply eating less, so keep meals balanced, with protein especially, stay hydrated and keep gentle activity going. For most people energy returns to normal within a few weeks, and you should tell your clinical team if tiredness is severe or not settling.¹

Practical steps help most people: eat smaller meals slowly, stop at the first feeling of fullness, favour plain lower-fat foods while adjusting, stay well hydrated, and avoid lying down straight after eating. If nausea or vomiting is persistent or you cannot keep fluids down, contact your clinical team — dehydration needs prompt attention.

Constipation is very common on Mounjaro for weight management (it may affect more than 1 in 10 people), because food moves through the gut more slowly and many people eat and drink less. Fluids come first, then fibre from vegetables and whole grains, then daily movement. If it persists, a pharmacist can recommend a suitable laxative.¹

For work, a few habits make a real difference. Many people choose an injection day that falls before a quieter stretch, such as a Friday evening or weekend, so that any peak in side effects lands away from meetings and travel. You can change your weekly injection day if needed, as long as at least 3 days (72 hours) have passed since your last dose.¹

None of this is a reason to avoid treatment. It is a reason to plan the early weeks sensibly, to keep your manager informed only as far as you wish, and to speak to the prescribing team early rather than struggling through. If a new dose is hard to tolerate, prescribers can hold the current dose longer before stepping up, and that can reduce disruption to your working life.¹

Because these effects are most likely during adjustment, any short-term time off in the first weeks could, for some people, partly offset the longer-term benefit that models describe. That is another reason not to take headline claims about absence at face value.

07 · Dose ladder and planning

Dose ladder: planning treatment around work

The dose ladder is gradual by design, which gives you predictable points to plan around. Everyone starts Mounjaro on 2.5mg once a week. This starting dose is about letting your body adjust, not about weight loss itself.¹ After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹

Many people settle at a maintenance dose of 5mg, 10mg or 15mg. Higher is not automatically better, and your prescriber will guide the right pace.¹ For anyone worried about time off, this is reassuring: you are not obliged to climb the ladder at maximum speed, and a slower pace can be chosen if side effects interfere with your working life.

Because side effects cluster around starting and stepping up, each increase is a small planning moment. You can look ahead at your calendar before a dose rise, avoid a heavy travel week, and make sure you have fluids, plain foods and a routine ready.

The mechanics of injecting are simple and fit around a job. Mounjaro is injected under the skin once a week, on the same day each week, at any time of day, with or without food.¹ Licensed injection sites are the stomach area (at least 5cm from the belly button), the front of the thigh, or the back of the upper arm if someone else gives the injection. Rotate the site with each dose. Each KwikPen contains four weekly doses.¹

Missing a dose is easy when work is busy, so know the rule. If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day. Never take two doses within 3 days of each other.¹

Setting a recurring phone reminder, or using the free GLPTrackr companion app to log each injection, can stop a hectic week from causing a missed dose. Our aftercare includes ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, so you are not left to work the schedule out alone.

The treatment is structured, slow and adjustable. If it is going to interfere with your work at all, the structure gives you ways to soften that, and your prescriber can hold or slow the ladder. That flexibility is a practical benefit to anyone who cannot afford to be unwell on a busy day.

08 · Serious effects and mood

Serious effects, mood and when to seek help

Serious side effects are uncommon, but they need urgent attention and they would mean time off work. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting, which could be pancreatitis. Also seek immediate medical help for pain in the upper right abdomen, fever or yellowing of skin or eyes, which could be a gallbladder problem, or for signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.¹

If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar, such as shakiness, sweating and confusion. Your prescriber may need to adjust those medicines.¹ Tell the prescribing team about every medicine you take, including anything from a hospital or specialist clinic. If you use the contraceptive pill, Mounjaro slows stomach emptying, which can reduce how well it is absorbed. Switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.

Mood is an area where people understandably want clarity. Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts: the EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link, and the MHRA keeps this under continuous review.¹⁷ That said, any big change in weight, appetite and routine can affect how you feel. Tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts during treatment.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

Hair and appearance concerns can affect confidence at work, so they deserve honest answers. Temporary hair shedding is a recognised side effect, reported as common in trials and linked to rapid weight loss itself rather than a direct drug effect. For most people it settles as weight stabilises, and protein intake and overall nutrition matter.¹ The same logic applies to changes in the face and skin. "Ozempic face" is not a drug effect; it is what losing a significant amount of weight quickly can do to facial volume, on any method including diet or surgery. The counter-measures are adequate protein, resistance exercise, and a loss pace guided by your prescriber rather than maximum speed.¹

Injection-site reactions are common and normally settle within a few days. Rotating sites each week and letting the pen warm briefly out of the fridge reduces stinging. Contact your clinical team if a reaction is spreading, hot, very painful, or lasts more than a week.¹ Local infections of the skin are a separate matter, and our page on skin infections and weight loss injections explains how to think about them.

Tell your prescriber about any new or lasting symptom, and you can report suspected side effects through the MHRA Yellow Card scheme.¹⁹ Reporting helps regulators spot patterns that individual patients cannot.

Importantly, severe symptoms are rare, and most people never face them. Anyone who does have a serious reaction needs rest and medical care, not a push to carry on working.

09 · Travel and shift work

Travel, holidays and shift work

Yes, you can plan treatment around holidays and business travel, provided you store the pen correctly. Keep Mounjaro pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use — useful for short trips — and must then be thrown away. Do not use a pen that has been above 30°C.¹ Keep the pen cap on to protect it from light, and never use a pen that has been frozen.

For unopened pens, store them in the fridge until first use; they keep until the printed expiry date. If you are unsure about an unopened pen that has been out of the fridge, check the patient information leaflet and ask the pharmacy rather than guessing.¹³ Our delivery uses temperature-controlled packaging, so a pen arrives ready to go in your fridge.

Travel raises a few practical questions. Carry your pen in hand luggage rather than the hold, where temperatures may be extreme and freezing is possible. Keep it in its original packaging, take your needles and a sharps solution with you, and carry a note from your prescriber if you are concerned about security checks. A small accessory such as an insulated travel case can be a low-cost addition. Avoid leaving a pen in a hot car or a bag in direct sun.

If your injection day falls on a travel day, you have options. You can change your weekly injection day if at least 3 days (72 hours) have passed since your last dose.¹ If you simply miss a dose while away, follow the missed-dose rule: take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day.¹ Do not double up.

Shift workers face a similar challenge. Because Mounjaro can be taken at any time of day, with or without food, the schedule is flexible enough for nights, rotas and irregular patterns. The key is consistency about the day, not the hour.¹ If your rota changes week to week, choose a day that is usually free, and set a reminder.

Holidays can also affect eating patterns. Rich food, alcohol and long journeys may make digestive effects feel worse, so keep fluids up and eat smaller meals slowly. If you are being sick and cannot keep fluids down, contact your clinical team — dehydration needs medical help straight away.¹

For people who work abroad or travel often, it can help to read the full detail in our weight loss injections FAQs before you go. The aim is that treatment fits around your job and your holidays, not the other way round.

10 · NHS and private routes

NHS, private treatment and employer schemes

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁶

That is relevant to any workplace discussion. If an employer wanted to support staff, the realistic routes are encouraging people to speak to their GP about NHS access, or signposting regulated private options. Anyone considering private treatment should check that the pharmacy is registered, and you can verify ours, GPhC 9012878, on the public register.¹²

Which injections the HSE approves, or whether the drugs payment scheme covers Mounjaro, are questions for the Irish system. We are a UK pharmacy, so for Irish reimbursement ask the HSE or your doctor.

Our process is a free online consultation, a review by a GPhC-registered prescriber, dispensing by our registered pharmacy and free next-day tracked delivery, with same-day dispatch when ordered by 3pm.

If you prefer to know about services near you, we have pages on weight loss injections in York, Wolverhampton and Congleton, and in Enniskillen. Online supply works the same wherever you live in the UK.

11 · Other injections and tablets

Other weight loss injections and tablets

Mounjaro is not the only licensed option, and readers often ask which is safer or newer. The honest answer is that safety and suitability depend on the person, and a prescriber is the right judge.

Wegovy (semaglutide) is a once-weekly injection with its own dose ladder. Its pens are 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly, with titration stepping up after at least four weeks, reaching the 2.4mg maintenance dose from week 17.¹⁸ The 2.4mg dose is the licensed maintenance dose for weight management.

Liraglutide, sold as Saxenda and in products such as Erly, is different in an important practical way. It is supplied at a concentration of 6mg per millilitre and is a daily injection, unlike once-weekly Mounjaro and Wegovy. Your prescriber can advise on how it compares for you.

Wegovy tablets (oral semaglutide) and Foundayo (orforglipron) are licensed tablet options with their own product information.²⁰²¹ Their trial results should not be compared with Mounjaro's, because the trials were not designed to be compared that way.

This matters to the sick-days question because no licence for any of these medicines claims a reduction in absence. Whichever option you consider, the sensible questions are the same. Is it licensed for my situation? What side effects should I plan for? How will it fit with my work and routine? Who will review me, and how often?

Cheaper, unregulated alternatives deserve a caution. Low-cost supplements marketed as natural versions of prescription injections carry dramatic weight-loss claims, but they come with no clinical oversight and their dosing is not standardised. They are not equivalent to licensed medicines. Equally, be wary of anyone offering to supply a prescription injection without a consultation or prescription, as counterfeit medicines are a real risk, and the MHRA publishes counterfeit alerts.⁷

Our own supply is official LillyDirect supply, sourced directly from Eli Lilly's UK distribution, with genuine KwikPens. That means you can be confident your pen is genuine. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

For wider context on how treatment fits into a healthy routine, see our weight loss clinic overview, which covers diet, activity and review expectations alongside the medicine itself.